Tharimmune rebrands to Canton Strategic Holdings with new NASDAQ ticker

Tharimmune, Inc. (NASDAQ: THAR) announced it will rebrand to Canton Strategic Holdings, Inc., with trading under the new ticker symbol "CNTN" beginning February 18, 2026, according to a company statement.

The company established its digital asset treasury strategy in November 2025 through a $545 million private placement. The strategy focuses on Canton Coin acquisition, operating a Super Validator, and investing in applications for the Canton Network across capital markets.

Recent company developments include securing approval as a Super Validator, appointing former CFTC Commissioner Jill Sommers and DRW Chief of Staff William Wiley to its board of directors, and completing a $55 million underwritten registered offering for additional growth capital.

"Since launching our digital asset treasury strategy, we have continued to execute against a clear mandate to support institutional adoption of the Canton Network," said Mark Wendland, Chairman and CEO.

The company operates clinical-stage biotech research and development in addition to its Canton Network activities. Canton Strategic Holdings remains supported by the Canton Foundation.

No action is required from stockholders regarding the corporate name change or ticker symbol modification. The press release notes that Digital Asset is not affiliated with Canton Strategic Holdings, Inc.

You May Also Be Interested In

• DDC Enterprise files annual report on Form 20-F for fiscal year 2025
• Marfrig unit launches tender offer for $467M in senior notes
• Keros Therapeutics doses first patient in Phase 2 DMD rinvatercept trial